31 results on '"Rivellini, Flavia"'
Search Results
2. Neuroimaging of leptomeningeal myelomatosis: a rare and severe entity
3. Eltrombopag for Low-Risk Myelodysplastic Syndromes With Thrombocytopenia: Interim Results of a Phase II, Randomized, Placebo-Controlled Clinical Trial (EQOL-MDS)
4. AVALON: The Italian cohort study on real-life efficacy of hypomethylating agents plus venetoclax in newly diagnosed or relapsed/refractory patients with acute myeloid leukemia
5. Eltrombopag for Low-Risk Myelodysplastic Syndromes With Thrombocytopenia: Interim Results of a Phase-II, Randomized, Placebo-Controlled Clinical Trial (EQOL-MDS)
6. Health-related quality of life in transfusion-dependent patients with myelodysplastic syndromes: a prospective study to assess the impact of iron chelation therapy
7. Feasibility and efficacy of dose-dense and dose-intense ABVD for high-risk patients with advanced Hodgkin lymphoma
8. Deferasirox for transfusion-dependent patients with myelodysplastic syndromes: safety, efficacy, and beyond (GIMEMA MDS0306 Trial)
9. Is Interim PET a Useful and Used Tool in Classical Hodgkin Lymphoma? Results from a Retrospective Multicenter Italian Experience
10. Perspectives and Emotional Experiences of Patients With Chronic Myeloid Leukemia During ENESTPath Clinical Trial and Treatment-Free Remission: Rationale and Protocol of the Italian Substudy
11. Phase I study of mitoxantrone, raltitrexed, levofolinic acid and 5-fluorouracil in advanced solid tumours
12. Cisplatin–epirubicin–paclitaxel weekly administration with G-CSF support in advanced breast cancer. A Southern Italy Cooperative Oncology group (SICOG) phase II study
13. Influenza Vaccination in Asplenia: Improving Quality of Care in Time of Coronavirus
14. SARS-CoV-2 in Myelodysplastic Syndromes: A Snapshot From Early Italian Experience
15. Azacitidine for the treatment of lower risk myelodysplastic syndromes: A retrospective study of 74 patients enrolled in an Italian named patient program
16. Vaccinazione Antinfluenzale in soggetti con Asplenia: warning in tempo di Coronavirus
17. Characterization of the rho genes of Neisseria gonorrhoeae and Salmonella typhimurium
18. Cisplatin (CDDP), raltitrexed (Tomudex, TOM), levofolinic acid (LFA) and 5-fluorouracil (5-FU) versus CDDP, methotrexate (MTX), LFA, and 5-FU in locally advanced (LAD) or metastatic (M) head and neck cancer (HNC). A phase II randomized study.
19. A PHASE II RANDOMIZED STUDY OF CISPLATIN (CDDP), TOMUDEX (TOM), LEVOFOLINIC ACID (LFA) AND 5-FLUOROURACIL (5-FU) VERSUS CDDP, METHOTREXATE (MTX), LFA, AND 5-FU IN LOCALLY ADVANCED (LAD) OR METASTATIC (M) HEAD AND NECK CANCER (HNC).
20. Iron-chelating therapy with deferasirox in transfusion-dependent, higher risk myelodysplastic syndromes: a retrospective, multicentre study
21. Feasibililty of Azacitidine As Bridge to Allogeneic Stem Cell Transplantation in Patients with Higher-Risk MDS or Low-Blast Count AML: Results of the BMT-AZA Multicenter Prospective Study
22. Feasibility and efficacy of dose‐dense and dose‐intense ABVD for high‐risk patients with advanced Hodgkin lymphoma
23. Health-related quality of life in transfusion-dependent patients with myelodysplastic syndromes: a prospective study to assess the impact of iron chelation therapy
24. Health-Related Quality Of Life In Transfusion-Dependent Patients With Myelodysplastic Syndromes Treated With Deferasirox. A Multicenter Prospective Study
25. Thrombosis History and Relationship With Low Thrombocytosis, Leukocytosis, and Other Characteristics At Diagnosis In 977 Essential Thrombocythemia Patients A Multivariate Analysis Of The Registro Italiano Trombocitemie (RIT)
26. 5-Azacytidine in 82 Low/Intermediate-1 IPSS Risk Myelodysplastic Syndromes: Results from the Italian Patient Named Program
27. Irinotecan and Mitomycin C in 5-Fluorouracil-Refractory Colorectal Cancer Patients
28. Alternative patterns of his operon transcription and mRNA processing generated by metabolic perturbation
29. A consensus motif common to all rho-dependent prokaryotic transcription terminators
30. Iron-chelating therapy with deferasirox in transfusion-dependent, higher risk myelodysplastic syndromes: a retrospective, multicentre study
31. AVALON: The Italian cohort study on real-life efficacy of hypomethylating agents plus venetoclax in newly diagnosed or relapsed/refractory patients with acute myeloid leukemia.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.